Anyone 40 or over can now receive AstraZeneca COVID vaccine, province announced April 19
Previously, administration of the AstraZeneca vaccine had been suspended for anyone except those aged 55 to 64 because it has caused a rare type of blood clot in some recipients, particularly among women in Europe. “Based on all of the evidence available internationally to date, we continue to believe benefits of the AstraZeneca/Covishield vaccine to protect against COVID-19 outweigh any potential risks,” said Dr. Joss Reimer, medical lead of the province’s Vaccine Implementation Task Force. “Expanding the criteria will help us reach more Manitobans, particularly those who may fac...